561 related articles for article (PubMed ID: 31620026)
1. Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Burns JA; Kroll DS; Feldman DE; Kure Liu C; Manza P; Wiers CE; Volkow ND; Wang GJ
Front Psychiatry; 2019; 10():626. PubMed ID: 31620026
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependence.
McCorkle ML; Kisor DF; Freiermuth CE; Sprague JE
Pharmacogenomics; 2021 Aug; 22(13):849-857. PubMed ID: 34424051
[TBL] [Abstract][Full Text] [Related]
3. Resting-State Neuroimaging and Neuropsychological Findings in Opioid Use Disorder during Abstinence: A Review.
Ieong HF; Yuan Z
Front Hum Neurosci; 2017; 11():169. PubMed ID: 28428748
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of the neurobiology of opioid use disorder: An overview.
Moningka H; Lichenstein S; Yip SW
Curr Behav Neurosci Rep; 2019 Mar; 6(1):1-11. PubMed ID: 34485022
[TBL] [Abstract][Full Text] [Related]
5. Prevention and Treatment of Opioid Misuse and Addiction: A Review.
Volkow ND; Jones EB; Einstein EB; Wargo EM
JAMA Psychiatry; 2019 Feb; 76(2):208-216. PubMed ID: 30516809
[TBL] [Abstract][Full Text] [Related]
6. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
7. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
[TBL] [Abstract][Full Text] [Related]
8. The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III.
Hassan AN; Le Foll B; Imtiaz S; Rehm J
Drug Alcohol Depend; 2017 Oct; 179():260-266. PubMed ID: 28818717
[TBL] [Abstract][Full Text] [Related]
9. Development of a Cascade of Care for responding to the opioid epidemic.
Williams AR; Nunes EV; Bisaga A; Levin FR; Olfson M
Am J Drug Alcohol Abuse; 2019; 45(1):1-10. PubMed ID: 30675818
[TBL] [Abstract][Full Text] [Related]
10. A review of opioid addiction genetics.
Crist RC; Reiner BC; Berrettini WH
Curr Opin Psychol; 2019 Jun; 27():31-35. PubMed ID: 30118972
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies.
Hansson AC; Gründer G; Hirth N; Noori HR; Spanagel R; Sommer WH
Neurosci Biobehav Rev; 2019 Nov; 106():141-164. PubMed ID: 30243576
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
Gondré-Lewis MC; Elman I; Alim T; Chapman E; Settles-Reaves B; Galvao C; Gold MS; Baron D; Kazmi S; Gardner E; Gupta A; Dennen C; Blum K
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453620
[TBL] [Abstract][Full Text] [Related]
13. Forging Neuroimaging Targets for Recovery in Opioid Use Disorder.
Stewart JL; May AC; Aupperle RL; Bodurka J
Front Psychiatry; 2019; 10():117. PubMed ID: 30899231
[TBL] [Abstract][Full Text] [Related]
14. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
[TBL] [Abstract][Full Text] [Related]
15. The failing cascade: Comorbid post traumatic stress- and opioid use disorders.
Elman I; Borsook D
Neurosci Biobehav Rev; 2019 Aug; 103():374-383. PubMed ID: 31063739
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
Hou H; Tian M; Zhang H
Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
[TBL] [Abstract][Full Text] [Related]
17. Addictions and stress: clues for cocaine pharmacotherapies.
Picetti R; Schlussman SD; Zhou Y; Ray B; Ducat E; Yuferov V; Kreek MJ
Curr Pharm Des; 2013; 19(40):7065-80. PubMed ID: 23574443
[TBL] [Abstract][Full Text] [Related]
18. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
[TBL] [Abstract][Full Text] [Related]
19. National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.
Gust SW; McCormally J
Curr Opin Psychiatry; 2018 Jul; 31(4):287-293. PubMed ID: 29771745
[TBL] [Abstract][Full Text] [Related]
20. Acute Negative Allosteric Modulation of M
Gould RW; Gunter BW; Bubser M; Matthews RT; Teal LB; Ragland MG; Bridges TM; Garrison AT; Winder DG; Lindsley CW; Jones CK
ACS Chem Neurosci; 2019 Aug; 10(8):3740-3750. PubMed ID: 31268669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
